Furthermore, HRD tumours have been reported to exhibit traits that may favour immune checkpoint blockade, such as high neoantigen load, increased PD-L1 expression, and increased levels of tumour-infiltrating lymphocytes [13]. The gene discussed is CD274; the disease is neoplasm.